Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome

Background: Endothelial dysfunction is the initial step for atherogenesis. Children with idiopathic nephrotic syndrome are at risk of endothelial dysfunction due to altered cholesterol metabolism which can lead to early atherosclerosis. Methods: In this analytical study with longitudinal follow up...

Full description

Bibliographic Details
Main Authors: Venkatesh Arumugam, Abhijeet Saha, Manpreet Kaur, Kanika Kapoor, Nimisha Arora, Trayambak Basak, Shantanu Sengupta, Ajay Bhatt, Nitin Bharadwaj, Vineeta V. Batra, Ashish Datt Upadhyay
Format: Article
Language:English
Published: BMC 2017-03-01
Series:Artery Research
Subjects:
Online Access:https://www.atlantis-press.com/article/125924994/view
_version_ 1818038100067090432
author Venkatesh Arumugam
Abhijeet Saha
Manpreet Kaur
Kanika Kapoor
Nimisha Arora
Trayambak Basak
Shantanu Sengupta
Ajay Bhatt
Nitin Bharadwaj
Vineeta V. Batra
Ashish Datt Upadhyay
author_facet Venkatesh Arumugam
Abhijeet Saha
Manpreet Kaur
Kanika Kapoor
Nimisha Arora
Trayambak Basak
Shantanu Sengupta
Ajay Bhatt
Nitin Bharadwaj
Vineeta V. Batra
Ashish Datt Upadhyay
author_sort Venkatesh Arumugam
collection DOAJ
description Background: Endothelial dysfunction is the initial step for atherogenesis. Children with idiopathic nephrotic syndrome are at risk of endothelial dysfunction due to altered cholesterol metabolism which can lead to early atherosclerosis. Methods: In this analytical study with longitudinal follow up 25 children with first episode of nephrotic syndrome (FENS) aged 1–16 years along with 25 age and gender matched healthy controls were enrolled. Endothelin 1 (ET 1) levels were measured by ELISA (Cloud Clone Corp. and assembled by USCN Inc, U.S.A). Other variables were measured using standard biochemical methods. Primary outcome measure was plasma ET 1 level in children with FENS and in controls. Secondary outcome measure was to observe the levels of ET 1 in children with FENS at 12 weeks in remission. Results: The level of ET 1 was significantly higher (p < 0.001) in children with FENS as compared to controls. The level of ET 1 was significantly higher (p = 0.006) in SSNS at the onset of nephrotic syndrome and was significantly lower (p = 0.04) after 12 weeks of drug induced remission as compared to controls. SRNS children had higher levels of ET 1 than the steroid sensitive patients at onset but in was not statistically significant (p = 0.062). ET 1 showed significant positive correlation with total cholesterol (r = 0.462; p = 0.001) and negative correlation with serum albumin (r = −0.565; p = 0.001). Conclusion: Plasma ET 1 levels are raised in children with FENS posing a risk of endothelial dysfunction, which persists at least in short term. Long term effects of raised plasma ET 1 needs to be studied.
first_indexed 2024-12-10T07:37:22Z
format Article
id doaj.art-519bd151d73d4619b5163910a265bed8
institution Directory Open Access Journal
issn 1876-4401
language English
last_indexed 2024-12-10T07:37:22Z
publishDate 2017-03-01
publisher BMC
record_format Article
series Artery Research
spelling doaj.art-519bd151d73d4619b5163910a265bed82022-12-22T01:57:24ZengBMCArtery Research1876-44012017-03-011810.1016/j.artres.2017.02.006Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndromeVenkatesh ArumugamAbhijeet SahaManpreet KaurKanika KapoorNimisha AroraTrayambak BasakShantanu SenguptaAjay BhattNitin BharadwajVineeta V. BatraAshish Datt UpadhyayBackground: Endothelial dysfunction is the initial step for atherogenesis. Children with idiopathic nephrotic syndrome are at risk of endothelial dysfunction due to altered cholesterol metabolism which can lead to early atherosclerosis. Methods: In this analytical study with longitudinal follow up 25 children with first episode of nephrotic syndrome (FENS) aged 1–16 years along with 25 age and gender matched healthy controls were enrolled. Endothelin 1 (ET 1) levels were measured by ELISA (Cloud Clone Corp. and assembled by USCN Inc, U.S.A). Other variables were measured using standard biochemical methods. Primary outcome measure was plasma ET 1 level in children with FENS and in controls. Secondary outcome measure was to observe the levels of ET 1 in children with FENS at 12 weeks in remission. Results: The level of ET 1 was significantly higher (p < 0.001) in children with FENS as compared to controls. The level of ET 1 was significantly higher (p = 0.006) in SSNS at the onset of nephrotic syndrome and was significantly lower (p = 0.04) after 12 weeks of drug induced remission as compared to controls. SRNS children had higher levels of ET 1 than the steroid sensitive patients at onset but in was not statistically significant (p = 0.062). ET 1 showed significant positive correlation with total cholesterol (r = 0.462; p = 0.001) and negative correlation with serum albumin (r = −0.565; p = 0.001). Conclusion: Plasma ET 1 levels are raised in children with FENS posing a risk of endothelial dysfunction, which persists at least in short term. Long term effects of raised plasma ET 1 needs to be studied.https://www.atlantis-press.com/article/125924994/viewEndothelin 1Nephrotic syndromeEndothelial dysfunctionChildren
spellingShingle Venkatesh Arumugam
Abhijeet Saha
Manpreet Kaur
Kanika Kapoor
Nimisha Arora
Trayambak Basak
Shantanu Sengupta
Ajay Bhatt
Nitin Bharadwaj
Vineeta V. Batra
Ashish Datt Upadhyay
Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
Artery Research
Endothelin 1
Nephrotic syndrome
Endothelial dysfunction
Children
title Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
title_full Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
title_fullStr Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
title_full_unstemmed Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
title_short Endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
title_sort endothelin 1 and endothelial dysfunction in children with idiopathic nephrotic syndrome
topic Endothelin 1
Nephrotic syndrome
Endothelial dysfunction
Children
url https://www.atlantis-press.com/article/125924994/view
work_keys_str_mv AT venkatesharumugam endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome
AT abhijeetsaha endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome
AT manpreetkaur endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome
AT kanikakapoor endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome
AT nimishaarora endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome
AT trayambakbasak endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome
AT shantanusengupta endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome
AT ajaybhatt endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome
AT nitinbharadwaj endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome
AT vineetavbatra endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome
AT ashishdattupadhyay endothelin1andendothelialdysfunctioninchildrenwithidiopathicnephroticsyndrome